Cargando…
Persistent immune thrombocytopaenic purpura associated with SARS‐CoV‐2 infection
Autores principales: | Furukawa, Yoshiki, Ando, Miki, Azusawa, Yoko, Kinoshita, Shintaro, Harada, Sakiko, Ochiai, Tomonori, Honda, Tadahiro, Sugimoto, Kazuya, Tabe, Yoko, Komatsu, Norio, Ando, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242397/ https://www.ncbi.nlm.nih.gov/pubmed/34226897 http://dx.doi.org/10.1002/jha2.201 |
Ejemplares similares
-
Advances in Allogeneic Cancer Cell Therapy and Future Perspectives on “Off-the-Shelf” T Cell Therapy Using iPSC Technology and Gene Editing
por: Furukawa, Yoshiki, et al.
Publicado: (2022) -
Trigenic ADH5/ALDH2/ADGRV1 mutations in myelodysplasia with Usher syndrome
por: Kinoshita, Shintaro, et al.
Publicado: (2021) -
SCLC-J1, a novel small cell lung cancer cell line
por: Ohara, Kazuo, et al.
Publicado: (2021) -
Long-term spontaneous regression of Stage IV diffuse large B-cell lymphoma
por: Furukawa, Yoshiki, et al.
Publicado: (2021) -
Danazol: An Effective Option in Acquired Amegakaryocytic Thrombocytopaenic Purpura
por: Mulroy, E., et al.
Publicado: (2015)